307 - The Compromised Immunocompromised Host

10/5/2019

3:15 PM - 4:30 PM

Room: Walter E. Washington Convention Center, 202 AB

MOC Credit: Maximum of 1.25 hours of MOC Credit
CME Credit: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-428-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

demonstrate the added infection risks associated with the use of newer immunotherapies in organ transplantation and oncology
review updates in HIV and transplantation
discuss the impact of aging and immunosenescence on infection risk in transplantation

Presentations:

3:15 PM - 4:30 PM
2884 - Infection and the Aging Transplant Recipient: Does Immune Senescence Increase Infection Risk?
Joanna M. Schaenman, MD, PhD – David Geffen UCLA School of Medicine
3:15 PM - 4:30 PM
2882 - Keeping up with the Nibs and the Mabs: New Therapies, New Risks?
Michail Lionakis, MD, ScD – National Institute of Allergy and Infectious Diseases
3:15 PM - 4:30 PM
2883 - Transplant and HIV Infection: Hoping for a Game Changer
Christine Durand, MD – Johns Hopkins

Moderator(s)

Rachel Miller, MD

Professor of Medicine
Duke University
Durham, NC

Disclosure: Synexis: Research Grant
Nina Clark, MD, FIDSA

Professor of Medicine
Loyola University Chicago Stritch School of Medicine
Maywood, IL

Disclosure: Ansun: Research Grant
Chimerix: Research Grant

Speaker(s)

Christine Durand, MD

Associate Professor
Johns Hopkins
Baltimore, MD

Disclosure: Abbvie: Grant/Research Support
Gilead Sciences: grant review committee, Other Financial or Material Support
GlaxoSmithKline/ViiV Healthcare: Grant/Research Support
Merck, Sharpe, and Dohme: Grant/Research Support
Michail Lionakis, MD, ScD

Chief, Fungal Pathogenesis Section, Laboratory of Clinical Immunology & Microbiology
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland

Disclosure: Nothing to disclose
Joanna Schaenman, MD, PhD

Associate Professor, Division of Infectious Diseases
David Geffen UCLA School of Medicine
Los Angeles, CA